CERUS CORP · held by 2 funds · data as of 2026-06-03
Sector
Healthcare
Industry
Medical Devices
Market cap
$541.00M
Price
$2.65
12-mo
+75.80%
Held by
2 funds
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for …